EZH2 Inhibition Interferes With the Activation of Type I Interferon Signaling Pathway and Ameliorates Lupus Nephritis in NZB/NZW F1 Mice

Overview of attention for article published in Frontiers in immunology, March 2021

Altmetric Badge

About this Attention Score

Average Attention Score compared to outputs of the same age
Average Attention Score compared to outputs of the same age and source

Mentioned by

twitter: 5 X users

Citations

dimensions_citation: 22 Dimensions

Readers on

mendeley: 23 Mendeley

Summary X Dimensions citations

So far, Altmetric has seen 12 X posts from 5 X users, with an upper bound of 21,879 followers.

"EZH2 inhibitor has the potential to inhibit IFN-I signaling pathway and alleviate lupus nephritis." https://t.co/QtdVpktMGz

20 May 2023

Reply Repost Favourite

@AmandaB55744931 HCQ inhibits EZH2 which can reactivate EBV but also inhibits type I interferon. Famciclovir + Celecoxib; Celecoxib reactivates EBV without weakening immune system. https://t.co/m9hmZ1HOM3 EZH2 inhibitors: Hydroxychloroquine https://t.c

25 Jul 2022

Reply Repost Favourite

https://t.co/HEYUtB1iOW

24 Jul 2022

Reply Repost Favourite

https://t.co/HEYUtB1iOW

14 Jul 2022

Reply Repost Favourite

This page shows the most recent X posts that mention this research output.

Click here to find out how to access more activity, including 8 additional X posts.